ThermDox: Liver Cancer Treatment Is A '$1 Billion Drug,' Drugmaker Says
Celsion shares closed up 3.7 percent to $2.22 on Tuesday, after trading as high as $2.32. "We believe we can be the best
thermdox liver cancer treatment  drug drugmaker say celsion share close percent  t USA ay trade high  believe good